image image image

“SEE-DRUG ” is a FP7 - RESEARH POTENTIAL project that aims to the upgrade the Structural Biology capacities of UPAT and to the Establishment of a Center of Excellence for Structure-Based Drug Target chracterization efforts in South-Eastern EU region.
Read the Full Story

“SEE-STRUCT” is structure-oriented module of SEE-DRUG project and aims to the structural elucidation of proteins, enzymes and other interesting drug-targets. The tools offered for these efforts are a state-of-the-art high field NMR instrument of 700 MHz equipped with a highly sensitive probe and crystallization robot.
Read the Full Story

“SEE-PROT” & “SEE-PHARM” are the protein production and the preclinical evaluation of molecules, modules of SEE-DRUG project. The tools offered for these efforts are protein production and characterization facilities an upgraded confocal microscope, an intravital microscope and myographs.
Read the Full Story

High sensetivity probe
Studies in solution
3D Structure determination, mobility, protein-protein interaction, protein-drug interactions
In-cell imaging
Leica Microscope
Tandem Scanner
Additional laser
Sub-cellular ablation in live cells, protein-complexes, protein drug interactions in vivo
Crystal growth
Crystalization trials
Fast & efficient
Crystal growth optimization, screen of protein targes in paraller with NRM Spectroscopy
intravital Microscope
In vivo
Ex vivo
Drug screening for anti-inflammatory compounds, evaluation of vasoactive compounds

Stuctural Biology
NMR & Xray
2H/13C/15N labeling
Selective labeling
Conformation dynamics, Modeling Structure determination, 3D solutions & crystal models, Bioinformatics
Molecular Biology
Biochemical pathways
Protein production
High-yield protein expression, labeling & isolation for structural studies, protein biochemistry
In-cell studies
Functional imaging
Light Microscopy
FRET measurements
Studies of biomolecular functions through Advanced Light Microscopy, Sub-cellular ablations
Vascular Biology
Cell-based assays
Signaling pathways
Monitoring cell processes (migration. proliferation, apoptosis), in vivo & ex vivo assays

Expertise Exchange
Knowledge transfer
Best practices
New applications
Exchange of researchers between UPAT and partnering organizations - EU Centers of excellence
Structural Biology
Workshops and scientific meetings will be organized at UPAT, Advanced training course in NMR
Biomolecular NMR
Life Sciences
Invited talks, Meeting participation & Poster presentations by SEE-DRUG members
Brokerage Events
Meet the expers
Links with industry
Regional Authorities
Colloquia with invited speakers from academia or industry and private sector stakeholders


One of the main axes of the SEE-DRUG Action Plan proposal principal axis is the establishment of an S&T Infrastructure to face new challenges in chemical and structural biology, drug design and preclinical drug screening. Therefore, SEE-DRUG Action plan has as a major axe the Upgrade and Renewal of the S&T Equipment of the UPAT facilities on protein production, NMR instrumentation, crystallization and complementary techniques, such as imaging, of great importance in the study of protein-protein/small molecule interactions and pharmacology.

The following activities are foreseen:

Upgrade the UPAT NMR capacity in Structural Biology by acquisition of a state-of-the-art high-field NMR Spectrometer with enhanced sensitivity for efficient screening of peptides and proteins prior to NMR studies, crystallization efforts and X-ray structural studies.
A high-field NMR instrument, such as a 700 MHz NMR with a cryogenically cooled probe for enhanced sensitivity, in concert with uniformly or selectively enriched recombinant proteins (in 13C, 15N and 2H), will enable SEE-DRUG members, national and regional research groups to study large proteins with molecular weight above 10 kDa.

NMR Room at the new Pharmacy Builging

Acquisition of a Crystallization Robot, which will be coupled with the NMR facility. Initial screening of protein-targets with NMR (to confirm, folding, oligomerization state, solubility etc.) will be followed by crystallization screening conditions in order to produce protein-substrate/drug complexes. The coupling of the two instruments will be time and cost-effective since it will reduce the false attempts to crystallize structureless or self-aggregating proteins.

Upgrade of the UPAT Advance Light Microscopy Facility. Upgrading of the existing Confocal Microscopy Facility, will comprise, according to our knowledge, a unique facility in Greece for its capacities, properties and applications. This equipment will be operated by an expert in confocal and functional microscopy, in collaboration with experts in molecular biology, in NMR and in in vivo assays.

Upgrade the UPAT molecular pharmacology laboratory bioactivity testing capacity with an Intravital Microscope and a set of Myographs.

Light Imaging Facility – Confocal microscope installed
at the lab of UPAT’s Medical School

Light Imaging Facility – Confocal microscope
installed at the lab of UPAT’s Medical School

Myographs (Dept of Pharmacy, UPAT)

Crystallization Robot installed at the UPAT’s Pharmacy Department

Upcoming Events

Hot off the Press

porn /div> The NMR Structure of ARKADIA RING Domain (Proteins 2012, 50, 1484-89)

H2S and NO in angiogenesis & vasodilatation (PNAS 2012 in the press)

Site Statistics

mod_vvisit_counterThis week282
mod_vvisit_counterLast week205
mod_vvisit_counterThis month741
mod_vvisit_counterLast month644
mod_vvisit_counterAll days213266

We have: 151 guests online
Your IP:
Today: Oct 22, 2019
University of Patras General Info, Services, Research Committee, etc.

FP7 Research & Innovation – Participants Portal – Calls for applications

International Meetings & Conferences

Journal Club

  • 01 Jan 2012 Starting data of SEE-DRUG project

  • 23 Feb 2012 Kick-off meeting

  • 23 Apr2012 External Advisory Board meeting

  • 29 Apr 2013 700MHz NMR installed